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CARDIOPULMONARY BYPASS, MYOCARDIAL 
MANAGEMENT, AND SUPPORT TECHNIQUES 
EFFECTS OF CARDIOPLEGIA 
ON VASCULAR FUNCTION 
AND THE "NO-REFLOW" 
PHENOMENON AFTER 
ISCHEMIA AND 
REPERFUSION: STUDIES IN 
THE ISOLATED BLOOD- 
PERFUSED RAT HEART 
The ability of cardioplegia to protect against cardiac contractile dysfunc- 
tion caused by ischemia and reperfusion is well established. The effects of 
cardioplegia on vascular injury and the no-reflow phenomenon, however, 
remain controversial. We used the blood-perfused rat heart to study the 
effect of St. Thomas' Hospital cardioplegic solution on postischemic 
endothelium-dependent a d endothelium-independent vascular function, 
the extent of the no-reflow phenomenon, and the temporal relationship 
between postischemic vascular and contractile function. Isolated rat hearts 
(16 per group) perfused with blood from a support rat at 60 mm Hg were 
subjected to 10, 20, 30 or 40 minutes of global ischemia and 40 minutes of 
reperfusion at 37 ° C. Eight hearts in each group also received cardioplegia 
(45 mm Hg for 2 minutes) before ischemia. Left ventricular developed 
pressure was measured with an intraventricular balloon. At the end of 
reperfusion, a bolus of 250 /.tg nitro-L-arginine methyl ester was infused to 
assess endothelium dependent vascular function. After a 20-minute wash- 
out, 25 ~g sodium nitroprusside was infused to assess endothelium- 
independent vascular function. Fluorescein (1 ml, 1% weight/volume) was 
then infused to assess no-reflow; this involved freezing the hearts, cutting 
them into transverse sections (10 >< 1 mm), video recording the sections 
under ultraviolet light, digitizing the images, and analyzing density of 
fluorescence. No-reflow was defined as a flow of less than 5%. Compared 
with nonischemic ontrol responses, endothelium-independent vascular 
function was significantly decreased only after 30 and 40 minutes of 
ischemia (48 .1% _ 3.8% and 24.3% -+ 7.4%, p < 0.05), but it was 
significantly protected by cardioplegia (66.6% -- 3.9% and 64.5% -+ 5.2%, 
p < 0.05). A significant reduction in endothelium-dependent vascular 
function was observed after 40 minutes of ischemia ( -31.8% _+ 6.6% vs 
-50.4% _ 1.6% in control hearts, p < 0.05), and again this was improved 
by cardioplegia ( -45.0% - 3.4%, p < 0.05 vs ischemic group). Areas of no 
reflow were present after 30 and 40 minutes of ischemia (11.9% _ 6.8% and 
33.4% _ 14.1% of left ventricular mass), and at each time period they were 
significantly decreased by cardioplegia (0.7% - 0.4% and 3.8% - 1.6%, p < 
0.05). Postischemic contractile dysfunction was observed before any vascu- 
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lar alteration was apparent. After only 20 minutes of ischemia, the 
postischemic recovery of left ventricular developed pressure fell to 56.7% - 
4.0%, but both endothelium-dependent vascular function and endothelium- 
independent vascular function were unaffected. In conclusion, vascular 
alterations are apparent only after prolonged periods of ischemia, longer 
than those required to observe contractile dysfunction, and cardioplegia 
protects against postischemic endothelium-dependent and endothelium- 
independent vascular dysfunction and reduces the extent of the no-reflow 
phenomenon. (J Tno~c CARDIOVASC SURG 1996;111:432-42) 
M ost studies on the consequences of myocardial ischemia and reperfusion have focused on the 
vulnerability of the myocyte to injury and on the 
ability of the heart to recover contractile function. 
Contractile end points have therefore been most 
commonly used in the development and assessment 
of cardioplegic solutions for clinical practice. Re- 
cently, however, there has been increasing interest 
in the effects of ischemia and reperfusion on the 
microvasculature and its function. 1It is now appre- 
ciated that the survival of the heart as a whole may 
in part depend on the ability of the microcirculation 
to deliver and distribute blood flow adequately 
during reperfusion. As a consequence, cardioplegic 
solutions have been reevaluated in a number of 
studies to ascertain whether their protective prop- 
erties extend to the coronary vasculature or whether 
these solutions may even be damaging to the micro- 
circulation and its function. The first report of a 
possible damaging effect of cardioplegia on the 
coronary vasculature was by Carpentier, Murawsky, 
and Carpentier 2 in 1981, who demonstrated a cyto- 
toxic effect of various cardioplegic solutions on 
cultured endothelial cells. Whether cardioplegic so- 
lutions can damage the vascular elements in whole 
hearts is less clear, but it has been proposed that the 
high potassium concentration of most solutions, z'4 
and other factors, such as high infusion pressures or 
flows, 5-7 may be deleterious. The elucidation of the 
effect of chemical cardioplegia per se on the vascu- 
lature is of course complicated by the coincidental 
effects of ischemia on the vascular elements. 
In this study, the isolated blood-perfused rat heart 
preparation was used to investigate the effect of St. 
Thomas' cardioplegic solution on postischemic en- 
dothelium-dependent vascular function (EDVF) 
and endothelium-independent vascular function 
(EIVF), the extent of the "no-reflow" phenomenon, 
and the temporal relationship between postischemic 
vascular alterations and contractile dysfunction. 
Material and methods 
Animals. Male Wistar rats weighing 200 to 250 gm 
(donor ats) and 400 to 450 gm (support rats) were used. 
All animals received care in compliance with the "Princi- 
ples of Laboratory Animal Care" formulated by the 
National Society for Medical Research and the "Guide for 
the Care and Use of Laboratory Animals" prepared by the 
Institute of Laboratory Animal Resources and published 
by the National Institutes of Health (NIH Publication No. 
86-23, revised 1985). 
Isolated blood-perfused rat heart preparation (Fig. 1). 
Support rats were anesthetized with pentobarbital (60 
mg/kg intraperitoneally) and placed supine on a heating 
pad (37.0 ° -+ 0.5 ° C). The rats were allowed to breathe 
spontaneously a humidified mixture of 95% oxygen plus 
5% carbon dioxide through aVenturi mask. The gas flow 
rate was set at 350 to 400 ml/min to maintain arterial 
oxygen and carbon dioxide tensions within the physiologic 
range (100 to 140 mm Hg and 35 to 45 mm Hg, respec- 
tively). The rats received anticoagulation with heparin 
(1000 IU/kg intravenously), and a femoral artery and vein 
were cannulated for the arterial blood supply to the donor 
heart and the return of blood to the support rat. Anes- 
thesia was administered as necessary (10 mg/kg pentobar- 
bital intraperitoneally). The support rats were used for no 
longer than 5 hours. 
Donor rats were anesthetized and given heparin in the 
same manner as support rats. Hearts were then rapidly 
excised and perfused in the Langendorff mode with arte- 
rial blood delivered from the support rat by a peristaltic 
pump. Perfusion was controlled with the aid of a pump 
speed driver that was designed to adjust the flow rate 
continuously to maintain aconstant aortic pressure of 60 
mm Hg. Coronary flow was calculated from the pump 
speed (a nomogram was used to calculate absolute flow 
from the number of revolutions per minute), which was 
recorded on chart paper throughout the experiment. The 
temperature of the blood and the isolated heart was 
maintained at 37.0 ° _+ 0.5 ° C by a thermostatically regu- 
lated heat-exchange system. Coronary effluent was col- 
lected into a venous reservoir and reinfused by gravity into 
the support rat through ablood filter (pore size 200/zm). 
A compliant balloon catheter attached to a pressure 
transducer was inserted into the left ventricle through the 
opened left atrial appendage and inflated to achieve a 
constant left ventricular end-diastolic pressure of 4 mm 
Hg. Heart rate was maintained at 380 beats/rain by right 
atrial pacing. 
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Fig. 1. Diagrammatic representation of the isolated blood-perfused rat heart preparation. LV, left 
ventricular. 
Protocol. Hearts (16 per group) were perfused aerobi- 
cally for 20 minutes to allow stabilization of temperature, 
heart rate, left ventricular end-diastolic pressure, left 
ventricular developed pressure (LVDP), and coronary 
flow and then randomly subjected to 10, 20, 30 or 40 
minutes (groups 1, 2, 3, and 4, respectively) of normother- 
mic global ischemia nd 40 minutes of reperfusion. Eight 
hearts in each group also received St Thomas' Hospital 
cardioplegic solution number 2 (110.0 mmol/L sodium 
chloride, 16.0 mmol/L potassium chloride, 16.0 mmol/L 
magnesium chloride, 1.2 mmol/L calcium chloride, and 
10.0 mmol/L sodium hydrogen carbonate) for 2 minutes at 
a perfusion pressure of 45 mm Hg. The postischemic 
recoveries of LVDP and coronary flow were continuously 
recorded. At the end of reperfusion, a 250/xg (3 mmol/L) 
bolus of nitro-L-arginine methyl ester (L-NAME) was 
infused to assess EDVF. After a 20-minute washout, 25 
txg (0.3 mmol/L) sodium nitroprusside (SNP) was infused 
to assess EIVF. This sequence of drug administration was 
deliberately chosen because of the long-lasting effects of 
L-NAME and the slow recovery of flow that occurs after 
its administration. This pattern contrasts with the shorter- 
lasting effects of SNP. During the assessment of vascular 
function, the hearts were unloaded by deflation of the 
intraventricular balloon. This was undertaken to minimize 
any possible changes in coronary flow during drug infusion 
that might occur in response to any changes in left 
ventricular work. Fluorescein (1 ml, 1% weight/volume) 
was infused 20 minutes after completion of the assessment 
of vascular eactivity. Hearts were then frozen to allow 
assessment of the no-reflow state. A time-matched aero- 
bic control group of hearts (n = 8) was aerobically 
perfused to obtain control vascular responses to L-NAME 
and SNP and the normal pattern of flow distribution. 
Preparation and infusion of drugs. L-NAME and SNP 
were obtained from Sigma Chemical Co. (Poole, United 
Kingdom). Drugs were dissolved in deionized water to 
obtain standard concentrations of 500 p.g/ml for L-NAME 
and 50/xg/ml for SNP. Aliquots of 0.5 ml were drawn into 
1 ml syringes. The solutions were frozen in the syringes 
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with liquid nitrogen and were then lyophilized for 24 
hours and stored at -30 ° C until use. Immediately before 
use, the drugs were redissolved in a fixed volume (0.7 ml) 
of arterial blood taken from the support animal; they were 
then infused into the isolated perfused heart. Because 
coronary flow varies, the same dose of drug was infused at 
different rates in different hearts to achieve the required 
blood concentration. This procedure was facilitated by the 
introduction of an infusion line in parallel with the main 
perfusion line. In this way, any changes in perfusion 
characteristics caused by alterations in blood volume, 
hematocrit, or viscosity were avoided (preliminary studies 
had shown that the coronary vasculature reacts to the 
infusion of volumes of normal saline solution as small as 
0.1 ml). During drug infusion, the coronary effluent was 
discarded and replaced with an equivalent quantity of 
fresh homologus blood to avoid any possible drug effect 
on the support rat. 
Assessment of flow distribution and calibration. At the 
end of the experimental protocol, hearts were switched to 
crystalloid Langendorff perfusion (bicarbonate buffer at 
60 mm Hg and 37 ° C) for 1 to 2 minutes to wash out blood 
from the coronary circulation. A bolus of fluorescein 
solution (1 ml, 1% weight/volume; Sigma Chemical) di- 
luted in bicarbonate buffer was then infused (60 mm Hg 
and 37 ° C) to delineate the distribution of flow. Hearts 
were then frozen and cut into 10 transverse sections 1mm 
thick. The right ventricle was separated from the rest of 
the heart. The surface fluorescein of the sections was then 
video recorded with a CCD camera (Pulnix America, Inc., 
Basingstoke, United Kingdom) in a dark room under 
standard conditions of illumination (long-wave ultraviolet 
light) and at a fixed focal distance and magnification with 
a macro-zoom lens (18 to 108 mm, f2.5 macro-zoom lens; 
RS Components Ltd., Corby, United Kingdom). Analog 
images were then digitized and analyzed for fluorescence 
density (NIH Image software, Twilight Clone BBS, Silver 
Spring, Md.). Calibration of the system was achieved by 
infusing decreasing concentration of fluorescein into a 
series of aerobically perfused hearts to obtain a correla- 
tion between density of tissue fluorescence and amount of 
infused fluorescein (Fig. 2, A). Gray;scale density (GSD), 
which ranges from 0 (absolute white) to 256 (absolute 
black), was used to measure the intensity of fluorescence, 
which was arbitrarily divided into three bands. Areas with 
GSDs less than 149 (amount of fluorescein >50%) were 
classified as having "good flow." Areas with GSDs of 150 
to 170 (amount of fluorescein 50% to 5%) were classified 
as having "low flow." Areas with GSDs greater than 171 
(amount of fiuorescein <5%) were classified as having 
"no flow." Fig. 2 (B) shows the typical flow distribution of 
aerobic ontrol hearts and hearts ubjected to 40 minutes 
of ischemia nd 40 minutes of reperfusion. 
Inclusion criteria. After instrumentation and 15 min- 
utes of aerobic perfusion, only isolated hearts with LVDP 
greater than 130 mm Hg and coronary flow between 1.7 
and 2.5 ml/min were entered in the study. Any excluded 
hearts were replaced immediately. 
Expression of results and statistical analysis. LVDP 
was calculated by subtracting left ventricular end-diastolic 
pressure from left ventricular systolic pressure. Postisch- 
emic recovery of LVDP was expressed as a percentage of 
the aerobic control value. Vascular responses after the 
administration of L-NAME and SNP were calculated as 
percentage changes of the baseline flow according to the 
following equation: 
% change in CF = (rCF × 100/iCF) - 100 
were CF is coronary flow, iCF is initial coronary flow 
(before drug infusion), and rCF is the coronary flow in 
response to drug infusion. For the assessment of tissue 
distribution of flow, the pixels with the same GSD present 
in the 10 images obtained from a single heart were added 
and then grouped in three GSD bands (1 to 149, 150 to 
170, and 171 to 256). The amounts of good flow, low flow, 
and no flow, corresponding to the number of pixels in 
each band, were expressed as percentage values of the 
total number of pixels in the heart. All results were 
reported as mean values + standard error of the mean. 
Correlation between amount of fluorescein (percentage of
control) and density of fluorescence (in GSDs) was car- 
ried out by linear regression analysis. Statistical evaluation 
of data was performed with analysis of variance. When the 
analysis of variance showed statistical significance (p -< 
0.05), the Student's t test with Bonferroni's correction was 
applied. 
Results 
Seven hearts were excluded from the study: five 
because of concomitant poor coronary flow and 
LVDP, two because of poor coronary flow alone, 
and one for excessive coronary flow. The aerobic 
control mean values for LVDP and coronary flow 
for all hearts in the study were 168 _+ 3 mm Hg and 
2.1 +_ 0.1 ml/min, respectively, and there were no 
significant differences between groups. 
Post isehemie recovery of LVDP. As shown in Fig. 
3 (A), the postischemic recovery of LVDP was little 
affected with mild (10-minute) ischemia. Prolonged 
periods of ischemia resulted in a progressive decline 
in recovery, however, so that after 40 minutes of 
ischemia recovery of LVDP was less than 15% of 
the preischemic aerobic control values. As expected, 
cardioplegia improved the recovery of LVDP in all 
instances. 
Post ischemic recovery of coronary flow. As 
shown in Fig. 3 (B), the postischemic recovery of 
coronary flow was not impaired by ischemic periods 
shorter than 20 minutes, a time at which the recov- 
ery of LVDP was already reduced by 50%. Recovery 
of coronary flow was only impaired after more 
severe ischemia, with recovery falling to 60% and 
24% after 30 and 40 minutes of ischemia, respec- 
tively. As observed with LVDP,  cardioplegia lso 
improved the postischemic recovery of coronary 
flow to 95% and 65% of their preischemic ontrol 
values after 30 and 40 minutes of ischemia, respec- 
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Fig. 3. Recovery of LVDP (A) and coronary flow (B), 
expressed as percentages of preischemic control values in 
the ischemia-only group (black bars) and cardioplegia 
group (cross-hatched bars) at different times of ischemia. 
Asterisk indicatesp < 0.05 between ischemia-alone group 
and corresponding cardioplegia group. 
tively (p < 0.05 vs corresponding ischemia-alone 
group). 
Post ischemic recovery of vascular function. As 
shown in Fig. 4, the vascular esponses to SNP and 
L-NAME in time-matched aerobic control hearts 
were 96.5% + 7.0% and -50.4% +_ 1.6%, respec- 
tively. As reflected by coronary flow, both EIVF and 
EDVF were not significantly affected by ischemic 
periods of 20 minutes or shorter. Extending the time 
of ischemia to more than 20 minutes, however, 
resulted in progressive vascular dysfunction with 
concomitant deterioration of EIVF and EDVF. 
Responses to SNP were reduced to 48.1% _+ 3.8% 
and 24.3% _+ 7.4%, and responses to L-NAME were 
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bars) after different durations of ischemia, Asterisk indi- 
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sponding Cardioplegia group. Dagger indicates p < 0.05 
versus nonischemic control group. 
reduced to -36.3% + 3.7% and -31.8% _+ 6.6% 
after 30 and 40 minutes of ischemia, respectively. 
The flow changes induced by SNP were in general 
more profound than those observed with ].-NAME, 
both with and without cardioplegia. This difference 
attained statistical significance in the groups sub- 
jected to 40 minutes of ischemia (p < 0.05). Inter- 
estingly, cardioplegia significantly improved EIVF 
and EDVF in all instances (66.6% _+ 3.9% and 
64,5% _+ 5.2% for SNP and -47.6% -- 1.2% and 
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cardioplegia group (cross-hatched bars) at different imes 
of ischemia. Asterisk indicates p < 0.05 between ischemia- 
alone group and corresponding cardioplegia group. 
-45.0% _+ 3.4% for L-NAME after 30 and 40 
minutes of ischemia; p < 0.05 for all values). 
Postischemic myocardial distribution of flow. As 
shown in Fig. 5, the myocardial distribution of flow 
was unaffected after ischemic periods of 30 minutes 
or shorter, a time at which the postischemic recovery 
of LVDP and coronary flow and vascular eactivity 
were already significantly impaired. The distribution 
of flow was significantly impaired after 40 minutes of 
ischemia, however; 33% _+ 14% of the left ventricle 
exhibited areas of no-reflow. Cardioplegia signifi- 
cantly reduced the no-reflow areas to 4% _+ 2% (p < 
0.05). Fig. 6 shows that no-reflow areas were located 
predominantly in the midmyocardium and endocar- 
dium and that this phenomenon was prevented to a 
large extent by cardioplegia. 
Discussion 
This study demonstrated that the contractile func- 
tion of the myocyte is more susceptible to ischemic 
injury than is the reactivity of the vasculature to 
vasoactive agents and that cardioplegia protects 
against postischemic vascular dysfunction and im- 
proves coronary vascular patency. These findings 
and their possible clinical implications are discussed 
further. 
Importance of the experimental preparation and 
the technique for the assessment of EDVF and 
E1VF. The effects of ischemia and reperfusion on 
the coronary vasculature have been investigated 
extensively with a wide variety of experimantal 
preparations, ranging from coronary artery rings to 
whole-heart preparations, both in vitro and in vivo. 
Each of these preparations has certain advantages 
and disadvantages. For example, vascular ings offer 
the convenience of an isolated preparation without 
the influence of neurohumoral factors or the effect 
of other tissue cell types (e.g., myocytes). Vascular 
rings are easily damaged uring preparation, how- 
ever, and administered agents can reach the vessel 
by both luminal and abluminal pathways. In addi- 
tion, vascular ings cannot provide information on 
the microvasculature. In vivo whole-heart prepara- 
tions do not have these inconveniences of vascular 
rings, but in these preparations the study of vascular 
reactivity is more difficult. Another approach to the 
study of vascular function is the use of isolated 
hearts; however, the common use of crystalloid 
solutions in these preparations causes unphysiologi- 
cally high coronary flows and vascular permeability 
alterations that may impair vascular eactivity dur- 
ing aerobic conditions. To overcome these prob- 
lems, we used the isolated rat heart perfused with 
whole blood from a support rat. In this preparation, 
the heart is perfused with autologous blood and the 
perfusion pressure can be tightly controlled. It 
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should be conceded that, although denervated, the 
isolated heart can be influenced by the depth of 
anesthesia of the support rat. This is, however, a 
situation that can be readily controlled so that heart 
rate and mean arterial pressure (data not shown) or 
the plasma levels of catecholamines (Lawson C, 
personal communication) in the support rat are not 
altered during the 5-hour experimental time. To 
separate the effects of ischemia and reperfusion 
from those of cardioplegia on the endothelium and 
smooth muscle of the vasculature, we used agents 
acting selectively on each of these elements. The 
nitric oxide donor SNP was used for the measure- 
ment of the EIVF. For the study of EDVF, the nitric 
oxide synthase inhibitor L-NAME was used. This 
choice was based on the consistently good responses 
obtained with this intervention i  previous tudies  
that used a preparation identical to the one in this 
study. In addition, our earlier studies showed that 
the use of nitric oxide synthase stimulators (such as 
acetylcholine, serotonin, and adenosine triphos- 
phate) afford smaller but less predictable responses. 
These results are supported by the findings of 
species differences in the distribution and activation 
of receptor subtypes. 9-12 
The relative susceptibilities of the myocytc and the 
coronary vasculature to ischemic injury. The precise 
temporal relationship between myocardial and vas- 
cular dysfunction induced by ischemia has not been 
clearly characterized, and to our knowledge this is 
the first study to investigate simultaneously the 
effects of increasing durations of ischemia on con- 
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tractile function, coronary flow, coronary respon- 
siveness, and vascular patency. Our results indicate 
that the myocyte is more susceptible to ischemic 
injury than is the vasculature, and the vascular 
smooth muscle is in turn more susceptible than is 
the endothelium. Kloner, Ganote, and Jennings 13 
studied dogs subjected to 40 and 90 minutes of 
regional ischemia nd 20 minutes of reperfusion, 
and suggest that the presence of no-reflow areas was 
caused by myocardial necrosis. In these studies, 
however, the assessment of tissue injury was carried 
out by ultrastructural techniques, and the question 
of which tissue component--the myocyte or the 
vasculature--was responsible for initiation of the 
no-reflow phenomenon could not be answered. In 
this connection, Dauber and coworkers 14 observed 
in anesthetized dogs subjected to 0, 15, 30 and 60 
minutes of regional ischemia nd reperfusion that 
functional abnormalities may precede morphologic 
changes. Contractile dysfunction was not reported 
in that study. In discussing relative patterns of injury 
and recovery, it is important to distinguish between 
vulnerability oinjury and the ease with which tissue 
recovers from injury. The fact that contractile func- 
tion is more rapidly injured than vascular function 
does not mean that its recovery isnecessarily faster. 
In this connection, Kim and associates 15 showed in 
the dog heart that, after 15 minutes of regional 
ischemia followed by 120 minutes of reperfusion, 
vascular dysfunction returned to normal completely 
within 90 minutes of reperfusion, whereas contrac- 
tility was still depressed after 120 minutes of reper- 
fusion. 
In our experiments, reduction in coronary flow 
occurred concurrently with alterations in EIVF 
rather than in EDVF, suggesting that injury to the 
vascular smooth muscle, rather than the endothe- 
lium, may account for the overall reduction in 
vascular responsiveness and increase in vascular 
resistance. Both vascular and contractile dysfunction 
preceded the onset of the no-reflow phenomenon. 
These results are supported by those of other inves- 
tigators howing increased vascular esistance and 
impaired coronary vascular eactivity after mild to 
moderate ischemiaJ 6-18 
The effect of cardioplegia on the postischemie 
recovery of vascular reactivity. In a previous tudy 
from our laboratory, 19 in which the isolated rat 
mesentery was perfused with a crystalloid solution 
and then subjected to ischemia, it was shown that 
cardioplegia dministered as a single dose neither 
protected nor injured the vasculature. Multiple in- 
fusions (every 30 minutes) of cardioplegia, however, 
conferred some protection on both endothelium and 
vascular smooth muscle. In these studies, in which 
the isolated rat heart was perfused with blood, 
single-dose cardioplegia resulted in a significant 
protection of endothelial nd vascular smooth mus- 
cle reactivity. The cardioplegia-induced protection 
of vascular reactivity was paralleled by concomitant 
protection of coronary flow and contractile function, 
and it also resulted in an amelioration of the no- 
re flow phenomenon. These results are supported by 
another study from our laboratory, 2° in which both 
single-dose and multidose cardioplegia fforded 
protection to the vasculature of the immature pig 
heart perfused with blood. 
In our studies, we used St. Thomas' Hospital 
cardioplegic solution. We did not explore the influ- 
ences of the individual components of the solution 
or of its mode of administration. It may therefore be 
possible that changing the composition of the car- 
dioplegic formulation (e.g., potassium or magne- 
sium concentration) or administering the solution in 
a different way from the one used in our studies may 
have different or even detrimental effects on the 
postischemic recovery of vascular eactivity. 
Possible clinical implications. This study shows 
that the St. Thomas' cardioplegic solution has no 
detrimental effects on the coronary vasculature of 
the rat heart. On the contrary, the solution affords 
protection of both contractile and vascular func- 
tion. Although these findings are necessarily im- 
ited by their observation i the rat heart, they do 
suggest that there may be scope for investigating 
whether solutions could be designed and opti- 
mized for the protection of the vasculature as well 
as the myocyte. 
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Discussion 
Mr. Magdi Yacoub (London, United Kingdom). I con- 
gratulate you on an extremely elegant study that used a 
blood-perfused isolated rat heart to examine several is- 
sues relating to vascular eactivity during repeffusion. 
I have several questions. First, although the blood- 
perfused isolated model you have used mimics physiologic 
conditions, how do you explain the extremely low coro- 
nary flow observed in your control animals when com- 
pared, for example, to crystalloid-perfnsed rat hearts, in 
which there is at least an eightfold to tenfold increase in 
flow? Do you think this is physiologic, or do you think that 
there is endothelial injury or generation of vasoactive 
peptides inherent in your model because of the use of a 
pumping apparatus? 
The second question relates to measurements of sys- 
tolic function. Do you think that measurement of gener- 
ated pressure at a predetermined nd-diastolic volume is 
enough to quantify mechanical function in an isovolumic 
model, or it would be more useful to use a pressure- 
volume relationship, as suggested by Webber and Geneke, 
particularly when the conditions of the heart will differ 
markedly before and after reperfusion? 
Third, how do you explain the vulnerability of the 
smooth muscle cell compared with the endothelial cell? 
Previous studies have suggested that endothelial cells are 
a lot more sensitive than smooth muscle cells. 
My final, possibly trivial, point is that when the animals 
are syngeneic have you excluded any immunologic effect? 
Some recent studies have shown that allogenic or xeno- 
geneic polymorphonuclear leukocytes are highly active 
against endothelial cells. 
Dr. Argano. In answer to your first question, we have 
made an effort to perfuse the isolated rat hearts with 
blood rather than a crystalloid solution because of the 
physiologic relevance of blood elements and vessel wall 
interactions. We have found from previous studies that 
the average coronary flow of the blood-perfused rat heart 
reflects more closely the coronary flow of the rat heart in 
vivo. We have also observed a stable level of catechol- 
amine levels for at least 5 hours of reperfusion. Although 
the high coronary flow in the crystalloid-perfused rat heart 
may be caused by the lower viscosity of the perfusion fluid, 
we have also observed a lower coronary vasodilator re- 
serve, which may suggest the presence of increased vaso- 
dilator tone in the crystalloid-perfused preparation. 
In answer to your second question, we did use pressure- 
volume curves to assess ystolic and diastolic function of 
all hearts. These were not shown today for the sake of 
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time and clarity and because they correlated well with the 
recovery of LVDP. 
In reply to your third question, we were surprised to see 
that vascular smooth muscle was somewhat more affected 
than the endothelium. Similar findings were obtained 
recently by Saldanha and Hearse in the isolated rat 
mesentery and published in T~E JOURNAL OF THORACIC 
AND CARDIOVASCULAR SURGERY. 
TO answer your final question, the animals were all 
syngeneic and we would not expect any immunologic 
effects. 
Dr. Franklin Lawrence Rosenfeldt (Melbourne, Austra- 
lia). My question centers around the ability of this prep- 
aration to allow you to separate out the individual pro- 
tective ffects of the cardioplegia on the myocardium from 
those on the coronary vasculature. Did 40 minutes of 
normothermic global ischemia result in a degree of isch- 
emic contracture? If so, could the protective ffect of the 
cardioplegia be acting more on the myocardium to pre- 
vent mechanical compression of the coronary circulation 
than on the coronary vaseulature directly? 
The classic way to study the integrity of the vasculature 
is by means of vessel rings in the organ bath. This allows 
one to study the effect of constrictors and dilators on the 
coronary vasculature itself. This technique can be minia- 
turized with a myograph, as shown by Mulvany and others 
(Mulvany M J, Halpern W. Contractile properties of small 
arterial resistance vessels in spontaneously hypertensive 
and normotensive rats. Circ Res 1997;41:19-26.), to work 
on very small blood vessels. 
Therefore, what proportion of the protective ffect was 
myocardial and what was truly vascular protection? 
Dr. Argano. I entirely agree with you that the study of 
vascular ings offers the convenience of an isolated prep- 
aration free from interference by other cell types, but it 
must be conceded that such preparations are not usually 
perfused with blood, that the isolation procedure is 
lengthy and may cause smooth muscle or endothelial 
damage, that drugs can reach the preparation from both 
the luminal and abluminal pathways, and that the vessels 
are usually arterial vessels rather than microvessels. Even 
with the Mulvaney myograph, a particularly demanding 
instrument used in our Physiology Department, I have 
rarely seen a vessel smaller than 400/xm mounted. 
Dr. Rosenfeldt. With the Mulvaney myograph, you can 
actually study the microvessels. 
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